- All sections
- C - Chemistrymetallurgy
- C40B - Combinatorial chemistrylibraries, e.g. chemical libraries
- C40B 30/04 - Methods of screening libraries by measuring the ability to specifically bind a target molecule, e.g. antibody-antigen binding, receptor-ligand binding
Patent holdings for IPC class C40B 30/04
Total number of patents in this class: 2216
10-year publication summary
|
174
|
143
|
139
|
136
|
158
|
110
|
89
|
98
|
80
|
49
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Prognosys Biosciences, Inc. | 104 |
52 |
| The Regents of the University of California | 19918 |
50 |
| President and Fellows of Harvard College | 5976 |
38 |
| University Health Network | 1043 |
30 |
| The Board of Trustees of the Leland Stanford Junior University | 6408 |
25 |
| Massachusetts Institute of Technology | 10057 |
22 |
| 10X Genomics, Inc. | 1209 |
21 |
| Bio-Rad Laboratories, Inc. | 1614 |
21 |
| The Johns Hopkins University | 5667 |
20 |
| Bioatla, Inc. | 106 |
20 |
| The University of British Columbia | 1501 |
17 |
| Chugai Seiyaku Kabushiki Kaisha | 1355 |
16 |
| Arizona Board of Regents on behalf of Arizona State University | 2625 |
15 |
| Celera Corporation | 78 |
15 |
| The Broad Institute, Inc. | 1808 |
14 |
| Janssen Biotech, Inc. | 1555 |
14 |
| Vibrant Holdings, LLC | 69 |
14 |
| Bristol-myers Squibb Company | 4898 |
13 |
| Keygene N.V. | 264 |
13 |
| Inscripta, Inc., FORMERLY Muse Biotechnology, Inc. | 309 |
13 |
| Other owners | 1773 |